Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 2, 2026 Show 4 more changesShow less
    • Primary endpoints: 17 to 3
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: 18 to 27
    • Site details revised
  2. Trial status: Active, Not Recruiting to Completed
    • Primary completion date changed from estimate of Feb 15, 2026 to Nov 26, 2025
    • Study completion date changed from estimate of Feb 28, 2026 to Nov 26, 2025
    v16
  3. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jan 31, 2026 to Feb 15, 2026
    • Site details revised
    v15
  4. Eligibility criteria expanded, about 1 wordv14
  5. Primary completion date: May 31, 2025 to Jan 31, 2026
    • Study completion date: Jul 31, 2025 to Feb 28, 2026
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Start date changed from estimate of May 31, 2024 to May 21, 2024v12
  2. Start date: Jun 15, 2024 to May 31, 2024
    • Eligibility criteria shortened, about 7 words
    v11
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 1, 2024 to Jun 15, 2024
    • Site details revised
    v10
  4. Start date: May 1, 2024 to Jun 1, 2024v9
  5. Re-verified, no change to tracked fieldsv8
  6. Start date: Mar 1, 2024 to May 1, 2024v7
  7. Start date: Jan 31, 2024 to Mar 1, 2024v6
  8. Start date: Dec 2023 to Jan 31, 2024v5
  9. Start date: Oct 2023 to Dec 2023v4
  10. Start date: Aug 2023 to Oct 2023
    • Primary completion date: Feb 1, 2025 to May 31, 2025
    • Study completion date: Feb 28, 2025 to Jul 31, 2025
    v3
  11. Start date: Mar 1, 2023 to Aug 2023v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial examines a web-based tool, in partnership with Peacefully, Inc, designed to improve end-of-life planning among patients with advanced cancers. This program helps users prepare comprehensively for end-of-life (e.g., medical wishes, legal estate planning, financial planning and transfer of accounts, legacy building, and emotional support). It is expected that this web-based end-of-life planning program may reduce distress and improve end-of-life preparation among advanced cancer patients.
Trial Details
NCT Number NCT05564468
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: National Institute of Nursing Research (NINR), Peacefully, Inc.
Conditions
(from sponsor)		 Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Related terms Neoplasm Metastasis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov